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Tobacco smoke is generated by the burning of a complex 
organic material including tobacco, additives, and paper, at an 
extremely high temperature. By smoking cigarettes, we can in-
hale an estimated 7,000 compounds, including numerous tox-
ic components such as benzene, formaldehyde, benzopyrene, 
carbon monoxide, acrolein, and even metals. These materials 
cause injury through inflammation, irritation, asphyxiation, 
carcinogenesis, and other mechanisms1. Many studies have 
revealed that smoking causes various diseases including lung 
cancer, bronchitis, coronary heart disease, stroke, cataracts, 
periodontitis, asthma, and hip fractures1. Passive (second-
hand) smoking is also a risk factor for diseases, including lung 
cancer, coronary heart disease, and lower respiratory illness2. 
In addition, smoking is deemed the single attributable risk fac-
tor for death3,4. In this issue, Park et al.5 have shown that smok-
ing is a contributable risk for various comorbidities including 
diabetes mellitus, metabolic syndrome, chronic obstructive 
pulmonary disease, stroke, angina, and malignancy. They also 
showed that smoking increased the risk of all-cause-mortality 
in a dose-response manner, using Korean national data, in 
this issue. The aforementioned study also showed that the 
attributable risks (ARs) of smoking for mortality were 21.8% 
in males and 9.0% in females during 2007–20155. Evidently, 
smoking is a death messenger.
Quitting smoking extends smokers’ lifespan by 10 years or 
more and helps them stay healthy6. Although many smokers 
attempt to quit smoking, the quit rate is low (2%–4%). Many 
drugs and devices, including varenicline, bupropion, nicotine 
patches, and nicotine gum have been developed to facilitate 
quitting smoking; however, their success rate is insufficient 
(20%–40%)7. Anti-smoking policies have been launched 
worldwide to overcome the limitations of personal strate-
gies. Governments have banned smoking advertisements 
and increased cigarette taxes. In Korea, the government has 
established the National Health Promotion Act in 1995, and 
launched various anti-smoking policies, abolishing military 
duty-free tobacco in 2009 and mandating the labeling of car-
cinogens on cigarette cases in 2011. In addition to designat-
ing non-smoking areas for public-use facilities in 2012, the 
government has expanded non-smoking areas, mandated 
that cigarette cases display warning pictures, and abruptly 
increased the cigarette tax by 80% in 2015 (Table 1). Although 
these national policies showed significant effects in reducing 
smoking rates8, the smoking rate remains high among males 
in Korea (66.3% in 1998 and 39.3% in 2015)9. Further smoking 
cessation strategies at the national level and in clinics should 
be maintained, improved, and tailored based on individual 
smokers’ circumstances10.
In this issue, Park et al.5 also showed that ARs of smoking 
for mortality decreased from 24.2% (2007–2010) to 19.5% 
(2011–2015) in men and from 9.5% (2007–2010) to 4.1% 
(2011–2015) in women. Although they showed no statistically 
significant difference between the two periods, decreasing 
trends are evident. The decreasing pattern of ARs of smoking 
for mortality might be due to governmental anti-smoking poli-
cies and the improvement of the smoking rate. Additionally, 
Table 1. Anti-smoking policies conducted by the Korean 
government
Year Policy
1995 Establishment of the National Health Promotion Act
Launch of anti-smoking policies
2005 Verification of Framework Convention on Tobacco 
Control (FCTC)
2009 Abolition of military duty-free tobacco
2011 Mandatory labeling of carcinogens on cigarettes cases
2012 Designation of “non-smoking areas” for public-use 
facilities
2015 Abrupt increase of tobacco prices (by 80%)
Mandatory warning picture on cigarettes cases
Expansion of “non-smoking areas”
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medical advances in the treatment of smoking-related dis-
eases might contribute to the reduced mortality. Specifically, 
molecular targeted therapies and immunotherapies have 
significantly improved the prognosis of lung cancer11, which 
is largely responsible for smoking-related deaths. Biologics 
in severe asthma, advanced interventional technologies in 
coronary artery disease, and new-generation anti-coagulants 
might also contribute to reducing smoking-related deaths. In 
addition, other new risk factors for death, including fine dust 
and e-cigarettes, could contribute to reducing the role played 
by smoking cigarettes among the attributable risk factors for 
death.
Smoking tobacco is, evidently, a risk factor for death. Vari-
ous pharmacotherapies have been developed to assist smok-
ing cessation, and national strategies have been launched to 
reduce smoking rates. Smoking rates and the attributable rate 
of smoking for mortality have decreased. However, the smok-
ing rate remains high, and smoking is still a significant attribut-
able factor for death. Further studies concerning smoking are 
needed.
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